Literature DB >> 15632401

Do beta-blockers and thiazides reduce fracture risk?

Mohit Bhandari1, P J Devereaux.   

Abstract

Entities:  

Year:  2005        PMID： 15632401      PMCID： PMC543941          DOI： 10.1503/cmaj.1041710

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Renal-metabolic consequences of antihypertensive therapy with diltiazem versus hydrochlorothiazide.

Authors:  E T Zawada; L Williams; D E McClung; J A TerWee; J Horning; R McNulty; M Thomas; J Simmons
Journal:  Miner Electrolyte Metab       Date:  1987

2.  Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial.

Authors:  A Z LaCroix; S M Ott; L Ichikawa; D Scholes; W E Barlow
Journal:  Ann Intern Med       Date:  2000-10-03       Impact factor: 25.391

3.  Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study.

Authors:  Julie A Pasco; Margaret J Henry; Kerrie M Sanders; Mark A Kotowicz; Ego Seeman; Geoffrey C Nicholson
Journal:  J Bone Miner Res       Date:  2004-01       Impact factor: 6.741

4.  Effects of propranolol on bone metabolism in the rat.

Authors:  B Minkowitz; A L Boskey; J M Lane; H S Pearlman; V J Vigorita
Journal:  J Orthop Res       Date:  1991-11       Impact factor: 3.494
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.